COSCIENS Biopharma's total assets for Q2 2024 were $50.05M, an increase of 57.41% from the previous quarter. TSE:CSCI total liabilities were $23.82M for the fiscal quarter, a 26.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.